1. Home
  2. SLRX vs BACK Comparison

SLRX vs BACK Comparison

Compare SLRX & BACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • BACK
  • Stock Information
  • Founded
  • SLRX N/A
  • BACK 2000
  • Country
  • SLRX United States
  • BACK United States
  • Employees
  • SLRX N/A
  • BACK N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • BACK Medical Specialities
  • Sector
  • SLRX Health Care
  • BACK Health Care
  • Exchange
  • SLRX Nasdaq
  • BACK Nasdaq
  • Market Cap
  • SLRX 2.5M
  • BACK 2.1M
  • IPO Year
  • SLRX N/A
  • BACK 2019
  • Fundamental
  • Price
  • SLRX $1.37
  • BACK $1.08
  • Analyst Decision
  • SLRX
  • BACK
  • Analyst Count
  • SLRX 0
  • BACK 0
  • Target Price
  • SLRX N/A
  • BACK N/A
  • AVG Volume (30 Days)
  • SLRX 42.5K
  • BACK 29.9K
  • Earning Date
  • SLRX 11-14-2024
  • BACK 12-03-2024
  • Dividend Yield
  • SLRX N/A
  • BACK N/A
  • EPS Growth
  • SLRX N/A
  • BACK N/A
  • EPS
  • SLRX N/A
  • BACK N/A
  • Revenue
  • SLRX N/A
  • BACK N/A
  • Revenue This Year
  • SLRX N/A
  • BACK N/A
  • Revenue Next Year
  • SLRX N/A
  • BACK N/A
  • P/E Ratio
  • SLRX N/A
  • BACK N/A
  • Revenue Growth
  • SLRX N/A
  • BACK N/A
  • 52 Week Low
  • SLRX $1.26
  • BACK $0.98
  • 52 Week High
  • SLRX $7.27
  • BACK $7.75
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 41.48
  • BACK 43.58
  • Support Level
  • SLRX $1.37
  • BACK $0.98
  • Resistance Level
  • SLRX $1.44
  • BACK $1.13
  • Average True Range (ATR)
  • SLRX 0.07
  • BACK 0.10
  • MACD
  • SLRX -0.01
  • BACK -0.00
  • Stochastic Oscillator
  • SLRX 15.61
  • BACK 26.88

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About BACK IMAC Holdings Inc.

IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.

Share on Social Networks: